Casino game-maker International Game Technology (NYSE:IGT) has drawn takeover interest from MacAndrews & Forbes Holdings Inc., Apollo Global Management LLC (APO), GTECH SpA (GTKYY) and Carlyle Group L.P. (CG), Reuters reported Friday on its website, citing people familiar with the matter. International Game Technology (NYSE:IGT) net profit margin is 10.30% and weekly performance is 26.78%. On last trading day company shares ended up $15.86. Analysts mean target price for the company is $14.39. International Game Technology (NYSE:IGT) distance from 50-day simple moving average (SMA50) is 21.90%.
SouFun Holdings Ltd (NASDAQ:SFUN) was downgraded by equities research analysts at JPMorgan Chase & Co. from an “overweight” rating to a “neutral” rating in a research note issued to investors on Friday, TheFlyOnTheWall.com reports. SouFun Holdings Ltd (NYSE:SFUN) shares advanced 0.57% in last trading session and ended the day on $8.88. SFUN gross Margin is 83.90% and its return on assets is 25.80%.SouFun Holdings Ltd (NYSE:SFUN) quarterly performance is -46.60%.
Galena Biopharma Inc. (NASDAQ:GALE) on June 2 announced that data from the Company’s Phase 1 study with GALE-301, or Folate Binding Protein (FBP), was presented at the American Society of Clinical Oncology (ASCO) 50th Annual Meeting. The poster entitled, “Comparison of recurrent and nonrecurrent ovarian and uterine cancer patients undergoing adjuvant folate receptor vaccine therapy,” was presented during the Gynecologic Cancer General Poster Session. Galena Biopharma Inc. (NASDAQ:GALE) shares moved down -6.77% in last trading session and was closed at $2.89, while trading in range of $2.84 – $3.21. Galena Biopharma Inc. (NASDAQ:GALE) year to date (YTD) performance is -41.73%.
Xoma Corporation (NASDAQ:XOMA) is expecting clinical trial results for its drug Gevokizumab. Gevokizumab is being developed in a variety of indications, however, the trial that they are expecting results for is in a phase 3 trial for Behcet’s disease. The results for the phase 3 trial called EYEGUARD-B are expected before the end of June. XOMA Corp (NASDAQ:XOMA) ended the last trading day at $4.46. Company weekly volatility is calculated as 7.26% and price to cash ratio as 5.09.XOMA Corp (NASDAQ:XOMA) showed a negative weekly performance of -3.25%.
Meg Energy Corp (OTCMKTS:MEGEF) has earned a consensus recommendation of “Buy” from the fourteen brokerages that are presently covering the stock, AnalystRatingsNetwork reports. One analyst has rated the stock with a hold rating and twelve have given a buy rating to the company. The average 12-month price target among brokers that have updated their coverage on the stock in the last year is $46.67. On last trading day company shares ended up $36.74.